Oyster Venture Partners is now a One Nucleus Partner
Established in 1997, One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation centred on the Greater London-Cambridge-East of England corridor. Headquartered in Cambridge, at the heart of Europe’s largest Life Sciences & Healthcare cluster, One Nucleus supports those institutions, companies and individuals undertaking activity in or with the above region.
Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable its members to maximise their performance. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development.
Oyster Venture Partners is delighted to be joining One Nucleus as a Partner integrating with its leading Cambridge-centric Life Sciences partner network; one of healthcare’s world-class innovation epicentres.
“One Nucleus exists to support life science companies in translating their world-class science into innovative medicines and technologies that improve patient outcomes. This includes connecting the scientists and entrepreneurs within our network with investors and those who can facilitate essential deal flow. Oyster Venture Partners has a strong track record in advising nascent companies towards success and One Nucleus is delighted to be welcoming them to the Cambridge ecosystem and our Partner Programme.”
Tony Jones, CEO
“Opening a Cambridge base as soon as possible has been Oyster’s objective to strengthen its strategic industry position to further support its global investment-seeking client base. Partnering with One Nucleus was the natural choice and we look forward to connecting with the One Nucleus, their members and their extensive network.”
David D’Alton, Oyster co-founder.